(VIANEWS) – The Market ended the session with PCAS (PCA.PA) rising 10.77% to €7.20 on Wednesday while CAC 40 rose 0.28% to €7,403.83.
PCAS’s last close was €6.50, 30.56% below its 52-week high of €9.36.
About PCAS
PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
Earnings Per Share
As for profitability, PCAS has a trailing twelve months EPS of €-5.21.
Revenue Growth
Year-on-year quarterly revenue growth grew by 44.4%, now sitting on 226.4M for the twelve trailing months.
More news about PCAS (PCA.PA).
